Unity Biotechnology, Inc. Proceeds from Issuance Initial Public Offering
Unity Biotechnology, Inc. reported Proceeds from Issuance Initial Public Offering of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2021-03-23
- Unity Biotechnology, Inc. proceeds from issuance initial public offering for the quarter ending 2018-12-31 was $5.00K.
- Unity Biotechnology, Inc. proceeds from issuance initial public offering for the quarter ending 2018-09-30 was $0.00.
- Unity Biotechnology, Inc. proceeds from issuance initial public offering for fiscal 2020 was $0.00.
- Unity Biotechnology, Inc. proceeds from issuance initial public offering for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Unity Biotechnology, Inc. proceeds from issuance initial public offering for fiscal 2018 was $79.06M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-23 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-23 | |||
| 2018-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $5.00K derived: sum of 2 quarters · filed 2021-03-23 | $79.06M 10-K · filed 2021-03-23 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $79.05M 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $79.05M 10-Q · filed 2019-08-07 |